Home › NDC Lookup › Labelers › Merck Sharp & Dohme Llc

Merck Sharp & Dohme Llc NDCs and Package Codes

This page lists NDC package records associated with labeler code 00006 (Merck Sharp & Dohme Llc) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

179
Package NDCs
145
Products
145
Active listings
0
Discontinued
45
Ingredients
0
Therapeutic classes
16
Dosage forms
67
With NADAC pricing

Portfolio

Top ingredients
SOTATERCEPT-CSRK 20
pembrolizumab and berahyaluronidas... 10
sitagliptin and metformin hydrochl... 10
suvorexant 8
ertugliflozin and metformin hydroc... 8
LETERMOVIR 6
RALTEGRAVIR 5
aprepitant 5
Hepatitis B Vaccine (Recombinant) 5
pembrolizumab 4
By dosage form
TABLET, FILM COATED 47
INJECTION, SOLUTION 25
KIT 22
INJECTION, SUSPENSION 18
TABLET, FILM COATED, EXTENDED RELE... 6
CAPSULE 5
INJECTION, POWDER, LYOPHILIZED, FO... 4
INJECTION, POWDER, LYOPHILIZED, FO... 4

Browse records — 145 products

Drug / product Billing NDC NADAC / unit Status
ANTIVENIN Latrodectus mactans KIT Merck · NDC 00006-5424-02 · 1 KIT in 1 CARTON (0006-5424-02) * 2.5 mL in 1 VIAL (0006-4084-01) * 1 mL in 1 VIAL (0006-9011-00) 00006-5424-02 — On market View →
BELSOMRA suvorexant 20 mg/1 TABLET, FILM COATED Merck · NDC 00006-0335-13 · 1 BLISTER PACK in 1 CASE (0006-0335-13) / 3 TABLET, FILM COATED in 1 BLISTER PACK 00006-0335-13 — On market View →
BELSOMRA suvorexant 15 mg/1 TABLET, FILM COATED Merck · NDC 00006-0325-13 · 1 BLISTER PACK in 1 CASE (0006-0325-13) / 3 TABLET, FILM COATED in 1 BLISTER PACK 00006-0325-13 — On market View →
BELSOMRA suvorexant 5 mg/1 TABLET, FILM COATED Merck · NDC 00006-0005-13 · 1 BLISTER PACK in 1 CASE (0006-0005-13) / 3 TABLET, FILM COATED in 1 BLISTER PACK 00006-0005-13 — On market View →
BELSOMRA suvorexant 10 mg/1 TABLET, FILM COATED Merck · NDC 00006-0033-13 · 1 BLISTER PACK in 1 CASE (0006-0033-13) / 3 TABLET, FILM COATED in 1 BLISTER PACK 00006-0033-13 — On market View →
BRIDION sugammadex 100 mg/mL INJECTION, SOLUTION Merck · NDC 00006-5423-12 · 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-5423-12) / 2 mL in 1 VIAL, SINGLE-DOSE (0006-5423-02) 00006-5423-12 — On market View →
BRIDION sugammadex 100 mg/mL INJECTION, SOLUTION Merck · NDC 00006-5425-15 · 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-5425-15) / 5 mL in 1 VIAL, SINGLE-DOSE (0006-5425-05) 00006-5425-15 — On market View →
CANCIDAS CASPOFUNGIN ACETATE 7 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Merck · NDC 00006-3823-10 · J0637 · 1 VIAL, SINGLE-USE in 1 CARTON (0006-3823-10) / 10.8 mL in 1 VIAL, SINGLE-USE 00006-3823-10 — On market View →
CANCIDAS CASPOFUNGIN ACETATE 5 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Merck · NDC 00006-3822-10 · J0637 · 1 VIAL, SINGLE-USE in 1 CARTON (0006-3822-10) / 10.8 mL in 1 VIAL, SINGLE-USE 00006-3822-10 — On market View →
CAPVAXIVE Pneumococcal 21-valent Conjugate Vaccine 3 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN 4 ug/.5mL; 6A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN 4 ug/.5mL; 7F INJECTION, SOLUTION Merck · NDC 00006-4347-01 · 1 SYRINGE in 1 CARTON (0006-4347-01) / .5 mL in 1 SYRINGE (0006-4347-99) 00006-4347-01 — On market View →
CAPVAXIVE Pneumococcal 21-valent Conjugate Vaccine 3 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN 4 ug/.5mL; 6A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN 4 ug/.5mL; 7F INJECTION, SOLUTION Merck · NDC 00006-4347-01 · 1 SYRINGE in 1 CARTON (0006-4347-01) / .5 mL in 1 SYRINGE (0006-4347-99) 00006-4347-01 — On market View →
DELSTRIGO doravirine, lamivudine, and tenofovir disoproxil fumarate 100 mg/1; 300 mg/1; 300 mg/1 TABLET, FILM COATED Merck · NDC 00006-5007-01 · 30 TABLET, FILM COATED in 1 BOTTLE (0006-5007-01) 00006-5007-01 $92.893 /unit · NADAC On market View →
DELSTRIGO doravirine, lamivudine, and tenofovir disoproxil fumarate 100 mg/1; 300 mg/1; 300 mg/1 TABLET, FILM COATED Merck · NDC 00006-5007-01 · 30 TABLET, FILM COATED in 1 BOTTLE (0006-5007-01) 00006-5007-01 $92.893 /unit · NADAC On market View →
EMEND aprepitant 80 mg/1 CAPSULE Merck · NDC 00006-0461-02 · J8501 · 2 CAPSULE in 1 DOSE PACK (0006-0461-02) 00006-0461-02 $208.983 /unit · NADAC On market View →
EMEND aprepitant KIT Merck · NDC 00006-3862-03 · J8501 · 1 KIT in 1 DOSE PACK (0006-3862-03) * 1 CAPSULE in 1 CAPSULE * 1 CAPSULE in 1 CAPSULE 00006-3862-03 — On market View →
EMEND FOSAPREPITANT DIMEGLUMINE 150 mg/5mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Merck · NDC 00006-3061-00 · J1453 · 1 VIAL, SINGLE-DOSE in 1 CARTON (0006-3061-00) / 5 mL in 1 VIAL, SINGLE-DOSE (0006-3061-01) 00006-3061-00 — On market View →
EMEND aprepitant 125 mg/1 POWDER, FOR SUSPENSION Merck · NDC 00006-3066-03 · J8501 · 1 POUCH in 1 CARTON (0006-3066-03) / 1 POWDER, FOR SUSPENSION in 1 POUCH (0006-3066-01) 00006-3066-03 $327.384 /unit · NADAC On market View →
ENFLONSIA CLESROVIMAB 150 mg/mL INJECTION, SOLUTION Merck · NDC 00006-5073-01 · 1 SYRINGE, GLASS in 1 CARTON (0006-5073-01) / .7 mL in 1 SYRINGE, GLASS (0006-5073-99) 00006-5073-01 — On market View →
ERVEBO ZAIRE EBOLAVIRUS (STRAIN KIKWIT-95) ENVELOPE GLYCOPROTEIN 72000000 [PFU]/mL INJECTION, SOLUTION Merck · NDC 00006-4293-02 · 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4293-02) / 1 mL in 1 VIAL, SINGLE-DOSE (0006-4293-01) 00006-4293-02 — On market View →
GARDASIL Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant 6 L1 CAPSID PROTEIN ANTIGEN 20 ug/.5mL; 11 L1 CAPSID PROTEIN ANTIGEN 40 ug/.5mL; 16 L1 CAPSID PROTEIN ANTIGEN 40 ug/.5mL; 18 L1 CAPSID PROTEIN ANTIGEN INJECTION, SUSPENSION Merck · NDC 00006-4109-02 · 10 SYRINGE in 1 CARTON (0006-4109-02) / .5 mL in 1 SYRINGE (0006-4109-01) 00006-4109-02 — On market View →
GARDASIL Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant 6 L1 CAPSID PROTEIN ANTIGEN 20 ug/.5mL; 11 L1 CAPSID PROTEIN ANTIGEN 40 ug/.5mL; 16 L1 CAPSID PROTEIN ANTIGEN 40 ug/.5mL; 18 L1 CAPSID PROTEIN ANTIGEN INJECTION, SUSPENSION Merck · NDC 00006-4045-00 · 1 VIAL, SINGLE-DOSE in 1 CARTON (0006-4045-00) / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4045-01) 00006-4045-00 — On market View →
GARDASIL 9 Human Papillomavirus 9-valent Vaccine, Recombinant 6 L1 CAPSID PROTEIN ANTIGEN 30 ug/.5mL; 11 L1 CAPSID PROTEIN ANTIGEN 40 ug/.5mL; 16 L1 CAPSID PROTEIN ANTIGEN 60 ug/.5mL; 18 L1 CAPSID PROTEIN ANTIGEN INJECTION, SUSPENSION Merck · NDC 00006-4121-02 · 10 SYRINGE, GLASS in 1 CARTON (0006-4121-02) / .5 mL in 1 SYRINGE, GLASS (0006-4121-01) 00006-4121-02 — On market View →
GARDASIL 9 Human Papillomavirus 9-valent Vaccine, Recombinant 6 L1 CAPSID PROTEIN ANTIGEN 30 ug/.5mL; 11 L1 CAPSID PROTEIN ANTIGEN 40 ug/.5mL; 16 L1 CAPSID PROTEIN ANTIGEN 60 ug/.5mL; 18 L1 CAPSID PROTEIN ANTIGEN INJECTION, SUSPENSION Merck · NDC 00006-4119-03 · 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4119-03) / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4119-01) 00006-4119-03 — On market View →
GARDASIL 9 Human Papillomavirus 9-valent Vaccine, Recombinant 6 L1 CAPSID PROTEIN ANTIGEN 30 ug/.5mL; 11 L1 CAPSID PROTEIN ANTIGEN 40 ug/.5mL; 16 L1 CAPSID PROTEIN ANTIGEN 60 ug/.5mL; 18 L1 CAPSID PROTEIN ANTIGEN INJECTION, SUSPENSION Merck · NDC 00006-4119-03 · 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4119-03) / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4119-01) 00006-4119-03 — On market View →
GARDASIL 9 Human Papillomavirus 9-valent Vaccine, Recombinant 6 L1 CAPSID PROTEIN ANTIGEN 30 ug/.5mL; 11 L1 CAPSID PROTEIN ANTIGEN 40 ug/.5mL; 16 L1 CAPSID PROTEIN ANTIGEN 60 ug/.5mL; 18 L1 CAPSID PROTEIN ANTIGEN INJECTION, SUSPENSION Merck · NDC 00006-4121-02 · 10 SYRINGE, GLASS in 1 CARTON (0006-4121-02) / .5 mL in 1 SYRINGE, GLASS (0006-4121-01) 00006-4121-02 — On market View →
IDVYNSO Doravirine, Islatravir 100 mg/1; .25 mg/1 TABLET, FILM COATED Merck · NDC 00006-5092-01 · 30 TABLET, FILM COATED in 1 BOTTLE (0006-5092-01) 00006-5092-01 — On market View →
IMIPENEM ANHYDROUS, cilastatin, and RELEBACTAM ANHYDROUS 500 mg/100mL; 500 mg/100mL; 250 mg/100mL INJECTION, POWDER, FOR SOLUTION Merck · NDC 00006-0138-01 · 221 VIAL, SINGLE-DOSE in 1 TRAY (0006-0138-01) / 20 mL in 1 VIAL, SINGLE-DOSE 00006-0138-01 — On market View →
INVANZ ertapenem sodium 1 g/1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Merck · NDC 00006-3843-71 · 10 VIAL, SINGLE-DOSE in 1 TRAY (0006-3843-71) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE 00006-3843-71 — On market View →
ISENTRESS RALTEGRAVIR 100 mg/1 TABLET, CHEWABLE Merck · NDC 00006-0477-61 · 60 TABLET, CHEWABLE in 1 BOTTLE (0006-0477-61) 00006-0477-61 — On market View →
ISENTRESS RALTEGRAVIR 100 mg/1 GRANULE, FOR SUSPENSION Merck · NDC 00006-3603-60 · 60 PACKET in 1 CARTON (0006-3603-60) / 1 GRANULE, FOR SUSPENSION in 1 PACKET (0006-3603-01) 00006-3603-60 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.